Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Sanofi American Depositary Receipt(SNY US)

$41.60-0.360.86%Ext:$41.68+0.080.19%(Market Closed · 00:00:02 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner
EDINET Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
SNY US​

SEC Filings by Owner

Insider Ownership

Sanofi(90)

  • 4Statement of changes in beneficial ownership12 Aug
  • 3Initial statement of beneficial ownership12 Aug
  • 4Statement of changes in beneficial ownership7 Aug
  • 3Initial statement of beneficial ownership4 Aug
  • 3Initial statement of beneficial ownership13 Aug 2024
  • 4Statement of changes in beneficial ownership14 Sep 2021
  • 3Initial statement of beneficial ownership12 Aug 2021
  • 4Statement of changes in beneficial ownership2 Aug 2021
  • 3Initial statement of beneficial ownership28 Jul 2021
  • 4Statement of changes in beneficial ownership29 Jul 2020

Sanofi-Aventis Amerique Du Nord S.N.C.(4)

  • 4Statement of changes in beneficial ownership14 Oct 2010
  • 3Initial statement of beneficial ownership11 Feb 2010
  • 4Statement of changes in beneficial ownership11 Feb 2010
  • 3Initial statement of beneficial ownership21 Dec 2007

AVENTIS INC(2)

  • 4Statement of changes in beneficial ownership11 Feb 2010
  • 3Initial statement of beneficial ownership11 Feb 2010

River Acquisition Corp.(2)

  • 4Statement of changes in beneficial ownership11 Feb 2010
  • 3Initial statement of beneficial ownership11 Feb 2010

GC Merger Corp.(2)

  • 4Statement of changes in beneficial ownership8 Apr 2011
  • 3Initial statement of beneficial ownership6 Apr 2011

≥5% Ownership

Sanofi(81)

  • SC 13GAgomab Therapeutics NV6 May
  • SC 13GInnate Pharma SA29 Apr 2025
  • SC 13G/AInnate Pharma SA29 Apr 2025
  • SC 13G/AMeiraGTx Holdings plc13 Aug 2024
  • SC 13GInhibrx Biosciences, Inc.31 May 2024
  • SC 13GMeiraGTx Holdings plc6 Nov 2023
  • SC 13GIcosavax, Inc.8 Feb 2022
  • SC 13DTranslate Bio, Inc.12 Aug 2021
  • SC 13GLAVA Therapeutics NV31 Mar 2021
  • SC 13GRevolution Medicines, Inc.11 Feb 2021

Amundi(13)

  • SC 13G/ASanofi22 Jul
  • SC 13G/ASanofi10 Apr
  • SC 13G/ASanofi17 Feb
  • SC 13G/ASanofi14 Nov 2025
  • SC 13G/ASanofi13 Aug 2025
  • SC 13G/ASanofi12 May 2025
  • SC 13G/ASanofi14 Feb 2025
  • SC 13G/ASanofi7 Nov 2024
  • SC 13G/ASanofi14 Feb 2024
  • SC 13G/ASanofi10 Feb 2023

TOTAL SA(10)

  • SC 13GSanofi14 Feb 2012
  • SC 13G/ASanofi-Aventis14 Feb 2011
  • SC 13G/ASanofi-Aventis12 Feb 2010
  • SC 13G/ASanofi-Aventis17 Feb 2009
  • SC 13G/ASanofi-Aventis14 Feb 2008
  • SC 13G/ASanofi-Aventis14 Feb 2007
  • SC 13G/ASanofi-Aventis14 Feb 2006
  • SC 13G/ASanofi-Aventis14 Feb 2005
  • SC 13G/ASanofi Synthelabo Sa13 Feb 2004
  • SC 13GSanofi Synthelabo Sa13 Feb 2003

BlackRock Inc.(9)

  • SC 13G/ASanofi6 Feb 2024
  • SC 13G/ASanofi7 Feb 2023
  • SC 13G/ASanofi3 Feb 2022
  • SC 13G/ASanofi1 Feb 2021
  • SC 13G/ASanofi10 Feb 2020
  • SC 13G/ASanofi11 Feb 2019
  • SC 13G/ASanofi8 Feb 2018
  • SC 13G/ASanofi27 Jan 2017
  • SC 13GSanofi9 Feb 2016

L OREAL S A(5)

  • SC 13G/ASanofi-Aventis14 Apr 2008
  • SC 13G/ASanofi-Aventis14 Apr 2008
  • SC 13G/ASanofi-Aventis13 Feb 2006
  • SC 13G/ASanofi Synthelabo Sa13 Feb 2004
  • SC 13GSanofi Synthelabo Sa13 Feb 2003

DODGE & COX(3)

  • SC 13G/ASanofi13 Feb 2024
  • SC 13G/ASanofi14 Feb 2023
  • SC 13GSanofi14 Feb 2022

CAPITAL GROUP INTERNATIONAL INC(3)

  • SC 13G/ASanofi-Aventis14 Feb 2005
  • SC 13G/ASanofi Synthelabo Sa13 Feb 2004
  • SC 13GSanofi Synthelabo Sa11 Feb 2003

KUWAIT PETROLEUM CORP(2)

  • SC 13G/ASanofi-Aventis13 Sep 2004
  • SC 13GSanofi Synthelabo Sa23 Aug 2004

BlackRock, Inc.(1)

  • SC 13G/ASanofi23 Apr 2025